A Drug Interaction Study to Assess the Pharmacokinetics of Narlaprevir and Antiretroviral Drugs
Condition(s):HealthyLast Updated:February 19, 2019Completed
Hide Studies Not Open or Pending
Condition(s):HealthyLast Updated:February 19, 2019Completed
Condition(s):Infection, Human Immunodeficiency VirusLast Updated:April 22, 2013Completed
Condition(s):HIV InfectionsLast Updated:November 30, 2023Active, not recruiting
Condition(s):Infection, Human Immunodeficiency VirusLast Updated:February 21, 2019Completed
Condition(s):HIVLast Updated:February 24, 2012Terminated
Condition(s):HIV InfectionsLast Updated:June 28, 2017Completed
Condition(s):HIV InfectionsLast Updated:June 27, 2011Completed
Condition(s):Pulmonary Disease; Tuberculosis, Pulmonary; Tuberculosis; Multi Drug Resistant Tuberculosis; Drug Sensitive Tuberculosis; Drug-resistant Tuberculosis; Mycobacterium Tuberculosis InfectionLast Updated:May 19, 2023Completed
Condition(s):Acquired Immune Deficiency Syndrome; AIDS; Human Immunodeficiency Virus; HIV InfectionsLast Updated:February 4, 2016Completed
Condition(s):Amyotrophic Lateral SclerosisLast Updated:June 12, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.